Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent
- PMID: 30820144
- PMCID: PMC6377374
Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent
Abstract
Purpose: Smoking and the incidence of age-related macular degeneration (AMD) have been linked to an overactive complement system. Here, we examined in a retrospective cohort study whether AMD-associated single nucleotide polymorphisms (SNPs), smoking, ethnicity, and disease status are correlated with blood complement levels.
Methods: Population: The study involved 91 AMD patients and 133 controls, which included 73% Americans of European descent (EUR) and 27% Americans of African descent (AFR) in South Carolina. Readouts: Participants were genotyped for 10 SNPs and systemic levels of complement factor H (CFH) activity, and the complement activation products C3a, C5a, and Bb were assessed. Main Outcome Measures: Univariate and multivariable logistic regression models were used to examine associations between AMD status and distinct readouts.
Results: AMD affects EUR individuals more than AFRs. EUR but not AFR AMD subjects revealed higher levels of Factors C3a and Bb. In all subjects, a 10-unit increase in C3a levels was associated with an approximately 10% increase in the odds of being AMD-positive, and C3a and Bb were associated with smoking. While CFH activity levels were not correlated with AMD, a significant interaction was evident between patient age and CFH activity. Finally, EURs had lower odds of AMD with enhanced copies of rs1536304 (VEGFA) and higher odds with more copy numbers of rs3766404 (CFH).
Conclusions: Our results support previous studies of systemic complement components being potential biomarkers for AMD, but they suggest that smoking and disease do not synergistically affect complement levels. We also suggest a novel susceptibility and protective haplotypes in the South Carolinian AMD population. Our studies indicate that augmented complement activation associated with advanced AMD could be attributed to a decrease in CFH activity in younger patients.
Figures



Similar articles
-
Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.PLoS One. 2014 Mar 27;9(3):e93459. doi: 10.1371/journal.pone.0093459. eCollection 2014. PLoS One. 2014. PMID: 24675670 Free PMC article.
-
Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5818-27. doi: 10.1167/iovs.09-3928. Epub 2009 Aug 6. Invest Ophthalmol Vis Sci. 2009. PMID: 19661236 Free PMC article.
-
Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.Ophthalmology. 2012 Feb;119(2):339-46. doi: 10.1016/j.ophtha.2011.07.056. Epub 2011 Nov 30. Ophthalmology. 2012. PMID: 22133792
-
CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues.Int J Mol Sci. 2024 Jan 30;25(3):1697. doi: 10.3390/ijms25031697. Int J Mol Sci. 2024. PMID: 38338978 Free PMC article. Review.
-
The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?J Innate Immun. 2014;6(4):407-16. doi: 10.1159/000356513. Epub 2013 Dec 7. J Innate Immun. 2014. PMID: 24335201 Free PMC article. Review.
Cited by
-
The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases.J Neuroinflammation. 2022 Oct 8;19(1):251. doi: 10.1186/s12974-022-02605-9. J Neuroinflammation. 2022. PMID: 36209107 Free PMC article. Review.
-
The Relationship between Complements and Age-Related Macular Degeneration and Its Pathogenesis.J Ophthalmol. 2024 Jan 2;2024:6416773. doi: 10.1155/2024/6416773. eCollection 2024. J Ophthalmol. 2024. PMID: 38205100 Free PMC article. Review.
-
Genotyping of Clinical Parameters in Age-Related Macular Degeneration.Clin Ophthalmol. 2022 Feb 25;16:517-529. doi: 10.2147/OPTH.S318098. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35241908 Free PMC article.
-
Increased plasma level of terminal complement complex in AMD patients: potential functional consequences for RPE cells.Front Immunol. 2023 Jun 8;14:1200725. doi: 10.3389/fimmu.2023.1200725. eCollection 2023. Front Immunol. 2023. PMID: 37359546 Free PMC article.
-
Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy.Int J Mol Sci. 2021 Jan 25;22(3):1170. doi: 10.3390/ijms22031170. Int J Mol Sci. 2021. PMID: 33504013 Free PMC article. Review.
References
-
- Rudnicka AR, Kapetanakis VV, Jarrar Z, Wathern AK, Wormald R, Fletcher AE, Cook DG, Owen CG. Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis. Am J Ophthalmol. 2015;160:85–93. - PubMed
-
- Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, Burdon KP, Hebbring SJ, Wen C, Gorski M, Kim IK, Cho D, Zack D, Souied E, Scholl HP, Bala E, Lee KE, Hunter DJ, Sardell RJ, Mitchell P, Merriam JE, Cipriani V, Hoffman JD, Schick T, Lechanteur YT, Guymer RH, Johnson MP, Jiang Y, Stanton CM, Buitendijk GH, Zhan X, Kwong AM, Boleda A, Brooks M, Gieser L, Ratnapriya R, Branham KE, Foerster JR, Heckenlively JR, Othman MI, Vote BJ, Liang HH, Souzeau E, McAllister IL, Isaacs T, Hall J, Lake S, Mackey DA, Constable IJ, Craig JE, Kitchner TE, Yang Z, Su Z, Luo H, Chen D, Ouyang H, Flagg K, Lin D, Mao G, Ferreyra H, Stark K, von Strachwitz CN, Wolf A, Brandl C, Rudolph G, Olden M, Morrison MA, Morgan DJ, Schu M, Ahn J, Silvestri G, Tsironi EE, Park KH, Farrer LA, Orlin A, Brucker A, Li M, Curcio CA, Mohand-Said S, Sahel JA, Audo I, Benchaboune M, Cree AJ, Rennie CA, Goverdhan SV, Grunin M, Hagbi-Levi S, Campochiaro P, Katsanis N, Holz FG, Blond F, Blanche H, Deleuze JF, Igo RP, Jr, Truitt B, Peachey NS, Meuer SM, Myers CE, Moore EL, Klein R, Hauser MA, Postel EA, Courtenay MD, Schwartz SG, Kovach JL, Scott WK, Liew G, Tan AG, Gopinath B, Merriam JC, Smith RT, Khan JC, Shahid H, Moore AT, McGrath JA, Laux R, Brantley MA, Jr, Agarwal A, Ersoy L, Caramoy A, Langmann T, Saksens NT, de Jong EK, Hoyng CB, Cain MS, Richardson AJ, Martin TM, Blangero J, Weeks DE, Dhillon B, van Duijn CM, Doheny KF, Romm J, Klaver CC, Hayward C, Gorin MB, Klein ML, Baird PN, den Hollander AI, Fauser S, Yates JR, Allikmets R, Wang JJ, Schaumberg DA, Klein BE, Hagstrom SA, Chowers I, Lotery AJ, Leveillard T, Zhang K, Brilliant MH, Hewitt AW, Swaroop A, Chew EY, Pericak-Vance MA, DeAngelis M, Stambolian D, Haines JL, Iyengar SK, Weber BH, Abecasis GR, Heid IM. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134–43. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous